Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Identification of non-responders to levothyroxine therapy using tissue-level T4/T3 biomarkers
2017-003673-34Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levothyroxine sodium and liothyronine in hypothyroidism (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Biomarkers of T4 and T3 tissue-level action. Started Feb 2018; status: completed.
02
Drugs
levothyroxine sodiumliothyronine
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on 2017-003673-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003673-34.